A new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada between 2000 and 2022.
Nouscom raises $72m in Series C financing round to develop cancer vaccines – Pharmaceutical Technology
Share this article The company has several cancer vaccines in the pipeline, with some in clinical trials. Credit: wildpixel via Getty Images. Swiss biotech Nouscom